1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. India Carrier Screening Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Focus on preventive healthcare
3.2.1.2. High burden of genetic disorders
3.2.1.3. Rising disposable income
3.2.1.4. Government initiatives for prenatal screening, genetic counseling
3.2.2. Restraints
3.2.2.1. Limited awareness especially in rural areas
3.2.2.2. Cost factor
3.2.2.3. Lack of genetic counselors
3.2.3. Opportunities
3.2.3.1. Expansion of test panels
3.2.3.2. Technological advancements (NGS) for affordable & comprehensive tests
3.2.3.3. Telemedicine & online platforms for wider access
3.2.4. Challenges
3.2.4.1. Ethical considerations
3.2.4.2. Regulation & standardization of test procedures
3.2.4.3. Infrastructure limitations in rural areas
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. India Carrier Screening Market: Marketing Strategies
5. India Carrier Screening Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.1.1. Targeted Diseases Carrier screening
5.2.1.2. Expanded Carrier Screening
5.2.1.3. Customized Panel Testing
5.2.1.4. Predesigned Panel Testing
5.2.2. By Medical Conditions
5.2.2.1. Hematologic Conditions
5.2.2.2. Pulmonary Conditions
5.2.2.3. Neurological Conditions
5.2.2.4. Others
5.2.3. By Technology
5.2.3.1. DNA Sequencing
5.2.3.2. PCR (Polymerase Chain Reaction)
5.2.3.3. DNA Microarray
5.2.3.4. Other
5.2.4. By End User
5.2.4.1. Hospitals and Medical Centers
5.2.4.2. Clinical Laboratories
5.2.4.3. Fertility Clinics
5.2.4.4. Others
5.2.5. By Region
5.2.5.1. North India
5.2.5.2. South India
5.2.5.3. East India
5.2.5.4. West India
6. North India Carrier Screening Market
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Medical Conditions
6.2.3. By Technology
6.2.4. By End User
7. South India Carrier Screening Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Medical Conditions
7.2.3. By Technology
7.2.4. By End User
8. East India Carrier Screening Market
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Medical Conditions
8.2.3. By Technology
8.2.4. By End User
9. West India Carrier Screening Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Medical Conditions
9.2.3. By Technology
9.2.4. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. India Carrier Screening Company Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Escalating Geopolitical Tensions on India Carrier Screening Market
12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
12.1. Quest Diagnostics India Pvt Ltd
12.2. LabCorp India
12.3. Strand Life Sciences Pvt Ltd
12.4. Genetix Biotech Asia Pvt Ltd
12.5. Eurofins Genomics India Pvt Ltd
12.6. SRL Diagnostics
12.7. CORE Diagnostics Pvt Ltd
12.8. MedGenome Labs Pvt Ltd
12.9. Lifecell International Pvt Ltd
12.10. Xcode Life Sciences Pvt Ltd
12.11. Invitae Corporation
12.12. Illumina Inc.
12.13. Thermo Fisher Scientific Inc.
12.14. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.